Letter to the EditorIs pain in patients with haematological malignancies under-recognised? The results from Italian ECAD-O survey
Section snippets
Conflict of interest
None declared.
Acknowledgement
The study was partially supported by an educational grant from Grünhenthal-Formenti-Italia.
Contributors. EB and DS equally contributed to the study. DS, KDB, MB and MR performed the analysis; EB and ML wrote the paper; MB, MR and GT designed the study; DS, MB, CR, GT and MR revised the paper.
References (7)
- et al.
The final phase in acute myeloid leukaemia (AML): a study on bleeding, infection and pain
Leuk Res
(2003) - et al.
Prevalence, distress, management, and relief of pain during the last 3 months of cancer patients’ life. Results of an Italian mortality follow-back survey
Ann Oncol
(2009) - et al.
Pain and emotional distress in leukemia patients at diagnosis
Leuk Res
(2010)
Cited by (17)
What Is the Clinical Course of Hematologic Malignancies?
2023, Evidence-Based Practice of Palliative Medicine, Second EditionManagement of cancer pain in adult patients: ESMO Clinical Practice Guidelines
2018, Annals of OncologyCitation Excerpt :According to a systematic review published in 2014 [7] using the Pain Management Index (PMI) [8], approximately one-third of patients do not receive appropriate analgesia proportional to their pain intensity (PI). High prevalence has also been documented in haematology patients at diagnosis, during therapy and in the last month of life [9]. These data reinforce the recommendation that patients with advanced or metastatic cancer require management within an integrated system for palliative care [7].
Pain management
2012, Annals of OncologyCitation Excerpt :The study showed that patients were still classified as potentially under-treated in 25.3% of the cases (range 9.8%–55.3%). Contrary to the percentage of incidence of pain of haematological patients reported in the literature years ago (i.e. 5% with leukaemia and 38% with lymphoma), a substantial proportion of patients with haematological malignancies may suffer from pain not only in the last months of life (83%) [6, 9] but also at the time of diagnosis and during active therapies (67.3%) [9, 10]. according to the World Health Organization (WHO), the incidence of cancer was 12 667 470 new cases in 2008 and based on the projections, it will be >15 million in 2020 [11].